Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP news

Show

From To
The US Could Easily Hit Its 2020 HIV Prevention Goal By Using One Drug, Drexel Study Finds

If just a quarter of men who have same-sex intercourse and are at a high risk for HIV used daily preventive medicine, three out of every 10 HIV infections could be averted, according to a new Drexel University study.

Published
13 December 2017
From
Drexel Now
Many young US men at high risk for HIV do not take anti-HIV pill

Less than 4 percent of young adult men-who-have-sex-with-men in the U.S. – a population at significant risk of contracting the human immunodeficiency virus (HIV) – reported ever using the pill that protects them from the virus, in a recently published study.

Published
13 December 2017
From
Reuters
Brazil Fights HIV Spike in Youths With Free Preventive Drug

The Brazilian Health Ministry is paying Gilead Sciences, the American manufacturer of the drug, about 75 cents a dose, a fraction of the price users pay in the United States, where PrEP sells for upward of $1,600 for a month’s supply.

Published
12 December 2017
From
New York Times
Australian Labor party commits to $53m plan to 'make HIV history'

People at high risk of HIV would be given cheap access to a breakthrough preventative medicine under a federal Labor plan to make Australia the first nation in the world to win the fight against the virus that causes AIDS. The opposition's $53 million plan would dramatically expand state trials of the drug PrEP until it is approved for a federal subsidy, increase funding for HIV peak bodies and tackle rising transmission rates in Aboriginal communities.

Published
11 December 2017
From
Sydney Morning Herald
Setting the Standard: New prevention trials in the era of oral PrEP

There’s a lot going on in the world of HIV prevention research right now. One key issue is how participants might access oral PrEP as part of HIV prevention trials. It may seem simple: trial participants have the right to the highest standard of HIV prevention and care as part of participation. But the ethics, trial design issues and the mechanisms by which interventions are provided as standard of care are quite complex. Opinions differ and politics abound.

Published
08 December 2017
From
AVAC
The Most Anti-Gay Corporate Policy in America Today

It’s time to end the anti-gay PrEP exclusion in America’s insurance industry. Some of the largest insurance companies in the nation exclude PrEP users who individually apply for life insurance, long-term care insurance or disability insurance.

Published
08 December 2017
From
GLAD
What Do Transgender Women Want? Lessons Learned by Listening

When taken correctly, PrEP nearly eliminates the risk of HIV. Yet, for transgender women, seeking protection against HIV may come second to safety, mental health, and employment opportunities.

Published
05 December 2017
From
The Body Pro
One year in: lessons on rolling out an HIV prevention pill in South Africa

There is a high level of political will and desire in the government to rollout PrEP to young women who are at risk, but the health system requirements are complex. South Africa needs to pay careful attention to access and service delivery issues and constraints, and to engage communities as PrEP is scaled up so that its potential is fully realised.

Published
01 December 2017
From
The Conversation
Young, fabulous & at-risk? How SA is PrEPing young women for the HIV prevention pill

This tablet can help to protect South Africa's young women from contracting HIV.

Published
01 December 2017
From
Bhekisisa
World AIDS Day: Clients can handle the truth

When CATIE endorsed the U=U consensus statement this year, many lauded us for helping to spread the message across Canada. But we also faced resistance from those who felt the message was dangerous. We heard concerns about sharing this news with clients. Will people living with HIV and their partners abandon condoms? Will we see an upsurge in other sexually transmitted infections like gonorrhea? Will people no longer take the risk of HIV transmission seriously?

Published
01 December 2017
From
CATIE
← First12345...127Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.